Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease.

Teens who have parental permission to drink are more likely to develop unhealthy relationships with alcohol as adults, a study says.

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

What the latest research findings tell us about the risks of habitually using these common recreational substances.

(HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in alcohol use disorder (AUD), according to a study published online Feb. 12 in JAMA Psychiatry.

Semaglutide shows promise in reducing alcohol cravings and consumption. Could it be a future treatment for AUD?

alcohol use disorder symptoms, and alcohol-related harms in young adulthood.” Getty Stock Photo “It's not the harm reduction approach we thought it is,” Dr. Lisa Damour, clinical ...

Alcohol doesn’t just impact the liver, it wreaks havoc on the entire digestive system. From inflamed gums and acid reflux to ...

Excessive alcohol consumption is a significant public health concern, responsible for approximately 6% of all deaths and ...

alcohol use disorder symptoms, and alcohol-related harms in young adulthood.” “It's not the harm reduction approach we thought it is,” Dr. Lisa Damour, clinical psychologist and author of ...

Globally, there is a low rate of guideline-consistent treatment of mental and substance use disorders, with wide individual and country variations.